| Typicality: | 0.266 |
| Saliency: | 0.244 |
| against ebola | 12 | transitive-object |
| highly | 7 | degree |
| in the clinical trials | 7 | location |
| vaccine → be shown to be → protective | 9 |
| vaccine → be shown to provide → protection | 6 |
| vaccine → be demonstrated to be → protective | 3 |
| negative | neutral | positive |
| 0.017 | 0.413 | 0.569 |
| Raw frequency | 18 |
| Normalized frequency | 0.244 |
| Modifier score | 0.500 |
| Perplexity | 26.729 |